🟢 Actively Hiring · 2d ago ⏳ Closes in 88 days 🇺🇸 US Corridor 🛡️ US Work Authorization 🏢 FULL_TIME

Manager Clinical Trial Supply

🏢 Avadel Pharmaceuticals plc · 📍 United States · 🕒 Nov 14, 2026 · Ref: OP-VERIF-081162BC
Benchmark Compensation (Annual Base)
Salary Disclosed on Application
Full Benefits Package
Apply Directly →
🛡️ Career Integrity & Compliance Audit
✓ Verified Opening

This opening is authenticated by Www2. We enforce strict salary disclosure and guarantee zero processing or placement charges.

Employer Registration US State corporate entity
Wage Standards US DOL Fair Labor Standards Act
Applicant Protections 100% Free direct candidate application
SPONSORED CAREER ADVISORY AD

Position Overview & Specifications

About Avadel Pharmaceuticals plcWho We Are: Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Oxybate therapy is currently the standard of care for the treatment of excessive daytime sleepiness (EDS) and cataplexy in patients living with narcolepsy. However, other approved oxybate products are immediate release formulations requiring two nightly doses - one dose at bedtime and the second dose 2.5-4 hours later, in the middle of the night. LUMRYZ TM (sodium oxybate) extended release for oral suspension, applies our proprietary drug delivery technology to allow for a single bedtime dose, eliminating the need to have a forced awakening during the middle of the night and giving patients the chance for an uninterrupted night’s sleep. An extended-release medication sounds like a simple innovation, but it is what has been lacking for 20 years, and we believe this can be transformative for people with narcolepsy. For more information, please visit www.avadel.com or check out narcolespydisrupts.com. What We Do: LUMRYZ was approved by the U.S. Food and Drug Administration (FDA) on May 1, 2023, to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. The FDA also found LUMRYZ to be clinically superior to currently marketed twice-nightly oxybate products and granted LUMRYZ seven years of Orphan Drug Exclusivity. In particular, FDA found that LUMRYZ makes a major contribution to patient care over currently available, twice-nightly oxybate products by providing a once-nightly dosing regimen that avoids nocturnal awakening to take a second dose.
On March 30, 2023, we announced that we raised over $200M of committed capital to fully support the launch of LUMRYZ. Avadel’s market research suggests that LUMRYZ has the potential to command a meaningful share of the multi-billion-dollar narcolepsy treatment market. We are in full launch mode now, and we have a product that has the potential to transform the lives of people with narcolepsy. We have a great launch plan, and we’ve built a launch team that will work relentlessly to get LUMRYZ to the narcolepsy community.
How We Work: At Avadel, patients are the reason we exist, and our employees are our greatest competitive advantage – our “secret sauce.” The way we work is as important as the results we achieve. Our employees work together as ONE team and live our Values, which is what makes working at Avadel so special and why we will win for patients. Our ONE Team approach fosters a culture based on being relentless for patients, having confidence with humility, being courageous, taking insights to impact, and togetherness. In everything we do, we live the Avadel Values so we can be our best for our patients, our community and each other. We are seeking team members who have a passion for making a meaningful impact in the lives of patients. We need individuals who will dive in, roll up their sleeves, and join us in our mission to launch LUMRYZ for the narcolepsy community and be part of building and shaping an exciting future together.Position Summary:The Manager Clinical Trial Supply will be focused on clinical trials supply management with an opportunity to also work on a range of cross functional pharmaceutical development projects. This person will be responsible for ensuring the clinical supplies needed for Avadel clinical studies are provided on time and in accordance with protocol and applicable Drug Enforcement Agency (DEA) and regulatory requirements. This includes management and oversight of the planning, forecasting, sourcing, packaging, labeling, distribution and return of clinical supplies. Essential Functions:The Manager Clinical Trial Supply is responsible for planning, creating, and maintaining complex drug supply forecasts and associated Investigational Product (IP) supply project plans with input from Clinical Affairs, Technical Operations, Quality, Supply Chain and Medical as well as contract providers, throughout the duration of the trial.Lead identification of risks and opportunities, building and maintaining contingency and mitigation plans to ensure supply continuity for trial participants.Work with Clinical Affairs, Quality and Regulatory to develop label design and text for multiple countries/regions, as required.Initiate required activities and supply execution processes, as well as maintain oversight of the production, release, and distribution steps necessary to ensure a continuous supply of IP throughout the duration of the clinical trial.Responsible for executing and optimizing the IP distribution strategy, aligning with clinical study design, study activities and timelines to ensure limited IP waste.Actively participate in the development of pharmacy manuals with appropriate internal subject matter experts.Work with the cross functional study team to ensure optimal set-up, implementation, user testing and ongoing maintenance of the Interactive Response Technology (IRT) system.Actively participate in end-to-end IP supply management (distribution and returns/destruction), with input from the Clinical Affairs/Study teams.Work with the Clinical Affairs/Study teams to ensure compliance with DEA requirements, specifically the provision of DEA 222 forms on time, to avoid interruption to clinical site IP supply.Monitor inventory levels of bulk and finished good IP (including expiration) at all locations throughout the project life cycle.Acts as a key liaison between the Technical Operations, Quality and Clinical Affairs/Study teams and is the primary contact for all strategic clinical supply related issues, taking appropriate escalation measures from issue identification to resolution.Proactively build and maintain strong working relationships with the study team and with the CRO to ensure proactive or early reactive resolution of site supply challenges.Coordinate Quality Systems required documentation, including Deviations, Investigations, CAPA’s, Change Controls, Label and Product Specifications, and others as required.Ensure appropriate documentation of IP supply activities is provided to clinical trial teams for inclusion in the Trial Master File.Where required, the project manager will also be responsible for the management of IP supply for investigator-initiated studies, with input from Clinical Affairs, Technical Operations, Quality, Supply Chain and Medical. Experience and Qualifications:Bachelor’s degree (or equivalent) qualification in a Life Sciences, Engineering, or other relevant discipline.Previous experience in Clinical Trials Supply management field required.A thorough knowledge and understanding of DEA, cGMP, ICH/cGXP guidelines and global Health Authority requirements is preferred.Excellent written & verbal communication skills.Demonstrate organizational and time management skills.Exceptional interpersonal and negotiation skills.Proven ability to work effectively on own initiative and within a team environment.Willingness to adapt to flexible working hours, specifically to support team members and/or clinical sites on all US time zones and Ireland. Travel may be required, both domestic and international. Avadel is committed to facilitating an open, honest, inclusive, transparent, and productive work environment where we work together as ONE team and ONE culture to be our best for patients, customers, and each other. Avadel is committed to equal employment opportunities and non-discrimination in employment. We believe that all employees and applicants should be treated with courtesy, dignity, and respect. Avadel does not discriminate in employment on the basis of race, color, religion, sex, sexual orientation, national origin, age, disability, genetic information, marital status, ancestry, gender, gender identity, pregnancy, status as a covered veteran, or any other characteristic protected by federal, state, and/or local law. It is our intent to comply with federal, state, and local laws, regulations, and guidelines in our employment practices and in our service to our clients. This policy applies to all terms and conditions of employment including, but not limited to, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation, and training.
INTERNATIONAL TALENT PLACEMENT NETWORK SPONSORED

Ready to Apply for this Opportunity?

Submit your candidate profile directly. No intermediary fees, no recruiter lock-in.

Continue to Application → Browse More US Jobs

Similar Verified Career Openings